Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 no DAC & Ipamorelin Legal 2026 Status: Comparison Table

503B Outsourcing Facility Legal for research distribution; voluntary cGMP compliance Legal for research distribution; mandatory cGMP and batch testing Enforcement of existing cGMP standards made non-negotiable FDA registration, CoA with HPLC purity ≥98%, endot

This comparison does not assign a generated winner or score.

  • 503B Outsourcing Facility
  • Legal for research distribution; voluntary cGMP compliance
  • Legal for research distribution; mandatory cGMP and batch testing
  • Enforcement of existing cGMP standards made non-negotiable
  • FDA registration, CoA with HPLC purity ≥98%, endotoxin testing, sterility validation
  • Only reliably compliant pathway for interstate peptide distribution in 2026
  • 503A State Pharmacy Compounding
  • Legal for individual patient prescriptions under state law
  • Restricted. Peptides not on 503A bulk substances list require clinical necessity documentation
  • FDA interpretation removed most peptides from 503A eligibility
  • Prescriber justification, adverse event reporting, state board approval
  • Functionally unavailable for CJC-1295/Ipamorelin unless prescriber can document no FDA-approved alternative
  • Research Chemical Vendor (Non-Registered)
  • Grey-market; FDA enforcement sporadic
  • Active enforcement. 150+ cease-and-desist letters issued 2024–2026
  • FDA now cross-references seller websites against 503B registry
  • None. Operates outside regulated framework
  • High risk. Peptides may be chemically accurate but lack documentation trail required for institutional use
  • International Supplier (Non-U.S.)
  • Legal to import for personal research use under exemption
  • Import seizures increased 340% since March 2024 under unapproved drug enforcement
  • Customs and Border Protection now flags peptide shipments without institutional documentation
  • Institutional affiliation proof, research protocol reference, import license
  • Not viable for individual buyers. Seizure rate makes it unreliable even for legitimate research
More references

Related material